US Stock MarketDetailed Quotes

SPRY ARS Pharmaceuticals

Watchlist
  • 16.520
  • +1.290+8.47%
Close Oct 16 16:00 ET
  • 16.580
  • +0.060+0.36%
Post 20:01 ET
1.60BMarket Cap-35148P/E (TTM)

ARS Pharmaceuticals Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

ARS Pharmaceuticals Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 4 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2024/Q4-- / 4.050M--
--2024/Q3-- / 565.000K--
--2024/Q2500.000K / 666.670K--
--2024/Q10.000 / 0.000--
--2023/Q40.000 / 0.000--
DatePeriodRevenue/EstimateEarnings Call
--2024/Q4-- / 4.050M--
--2024/Q3-- / 565.000K--
--2024/Q2500.000K / 666.670K--
--2024/Q10.000 / 0.000--
--2023/Q40.000 / 0.000--

Unlock Free Earnings Estimates

ARS Pharmaceuticals Earnings Reports

  • ARS Pharmaceuticals | 10-Q: Q2 2024 Earnings Report

    Aug 6 16:12 ET

  • ARS Pharmaceuticals | 10-Q: Q1 2024 Earnings Report

    May 9 16:22 ET

  • ARS Pharmaceuticals | 10-K: FY2023 Annual Report

    Mar 21 22:22 ET

  • ARS Pharmaceuticals | 10-Q: Quarterly report

    Nov 9, 2023 16:04 ET

    • Read more

    Analysis

    Analyst Rating

    Updated: Sep 30, 2024

    Strong Buy

    • Buy

      100.00%

    • Hold

      0.00%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Latest Price
    % Chg

    No Data